© 2005-2012 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.
Research for inflammatory breast cancer is ongoing. The following advances may still be under investigation in clinical trials and may not be approved or available at this time. Always discuss all diagnostic and treatment options with your doctor.
The latest trend in research is looking at the effectiveness of targeted therapies combined with chemotherapy. The drug bevacizumab (Avastin) used in combination with the established drugs such as doxorubicin, paclitaxel, and docetaxel, is being evaluated. Bevacizumab is a new drug that works by blocking the growth of new blood vessels that can bring nutrients to the cancer cells, called anti-angiogenesis.
Looking for More about Current Research?
If you would like additional information about the latest areas of research regarding inflammatory breast cancer, explore these related items:
- To find clinical trials specific to your diagnosis, talk with your doctor or search online clinical trial databases now.
- Visit ASCO's CancerProgress.Net website to learn more about the historical pace of research for breast cancer.
Or, choose “Next” (below, right) to continue reading this detailed section.